Latest news
Equity research Immunovia, Q2 2026: MediCare submission and partnerships in focus - Carlsquare Corporate FinanceCarlsquare Corporate Finance · Fri, 07 Aug 2026 05:48:34 GMTResearch update Immunovia Q2 2026: MediCare submission and partnerships in focus - TradingViewTradingView · Fri, 07 Aug 2026 05:42:00 GMTImmunovia boosts PancreaSure uptake as clinical evidence builds and cash burn stays below guidance - TipRanksTipRanks · Thu, 06 Aug 2026 07:30:26 GMTSweden's Immunovia Q2 sales rise on PancreaSure test uptake - TradingViewTradingView · Thu, 06 Aug 2026 06:40:00 GMTImmunovia Publishes Interim Report for April-June 2026 - TradingViewTradingView · Thu, 06 Aug 2026 06:30:00 GMTImmunovia to Present Q2 2026 Report Amid Push in Pancreatic Cancer Diagnostics - TipRanksTipRanks · Mon, 03 Aug 2026 07:17:58 GMTImmunovia AB Revenue Breakdown – OMXSTO:IMMNOV - TradingViewTradingView · Mon, 27 Jul 2026 13:52:12 GMT